Diabetes Mellitus Foot Ulcer
Conditions
Keywords
diabetic foot ulcer, diabetes mellitus, fat grafting, platelet rich plasma, wound healing
Brief summary
Conventional management of diabetic ulcers is associated with slow healing, high costs and repeated trips to clinic. Stem cells contained in fat grafts can differentiate into pro-healing cells and release growth factors with evidence suggesting a benefit in wound healing. Platelet-rich-plasma (PRP), an autologous blood-product, demonstrates pro-healing properties through releasing pro-healing factors and regulating angiogenesis. When used combination there is evidence of additional wound healing benefits. The aim is to investigate the feasibility of conducting a randomised controlled trial with fat grafting and fat/PRP co-grafting as interventions for diabetic ulcers. We aim to develop pilot data which can power a multi-centre study. The aim of the trial would be to determine the feasibility of the trial by assessing recruitment, randomisation and retention of participants. We would also evaluate the rate of wound healing in diabetic ulcers when treated with conventional dressings, fat grafting alone and fat+PRP combination. The secondary aims will be to understand the mechanism of the healing process, the health related quality of life and patient satisfaction and the cost implications. The study is a single-blinded randomised controlled trial of approximately 30 patients with three parallel treatment arms. Each patient will be followed up for 12 weeks and the rate and degree of wound healing will be assessed. Wound biopsies will be taken at Day 0, week 1 and week 4 and will undergo subsequent histological analysis to evaluate the mechanism of healing. The study is expected to last two years from recruitment of the first patient and will be conducted at Royal Free Hospital and UCL Division of Surgery and Interventional Science. The combination of fat+PRP may provide diabetic patients the option of a single treatment with improved healing, shorter followup and a reduced cost burden. Validation of the mechanism of healing through histological analysis will confirm clinical findings and help guide future research.
Detailed description
RCT to compare fat grafting and fat grafting with PRP in chronic diabetic wounds.
Interventions
PROCEDUREFat grafting
Single treatment fat grafting infiltrated into diabetic ulcer wound
PROCEDUREFat grafting + platelet rich plasma
Single treatment fat grafting mixed with autologous platelet rich plasma infiltrated into diabetic ulcer wound. Autologous PRP is obtained using the ANGEL(TM) Concentrated Platelet Rich Plasma (cPRP) Separation Device which is FDA-regulated and CE certified
Sponsors
University College, London
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* Male or female; * Age 18-90 at the time of consent; * Diabetic foot ulcer (DFU) measuring more than 0.5cm x 0.5cm and less than 10cm x 10cm; * Wound with clean, healthy granulating bed, with minimal adherent slough; * Patient understands and is willing to participate and can comply with weekly visits and follow-up regime.
Exclusion criteria
* Wound with active infection; * Patients with underlying vascular insufficiency (ABPI\<0.3); * Uncontrolled Diabetes Mellitus, as measured by an HbA1c \> 90mmol/mol; * Presence of one or more medical conditions, including renal, hepatic, haematologic, active auto-immune or immune diseases that, would make the subject an inappropriate candidate for this ulcer healing study; * Patient not fit for surgery (ASA classification \> 4).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rate of wound healing | 12 weeks | Comparison of rate of wound healing between each group |
| Degree of wound healing | 12 weeks | Comparison of degree of wound healing (50% and 100% re-epithelialisation) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Mechanism of wound healing | 12 weeks | Histological analysis of wound biopsies from each group at day 0, week 1 and week 4 |
| Health related quality of life | 12 weeks | Patient quality of life with each procedure |
| Cost implications | 12 weeks | Cost implications of each treatment arm as per NHS coding practice |
| Patient reported outcome measures | 12 weeks | Patient reported outcome measures of satisfaction of each procedure |
Countries
United Kingdom
Outcome results
None listed